Fundação Cristiano Varella

What Fundação Cristiano Varella does

Fundação Cristiano Varella is a private, non-profit charitable foundation (entidade filantrópica, CNPJ 00.961.315/0001-03) established on September 4, 1995 in Muriaé, Minas Gerais, Brazil, by former federal deputy Lael Varella and his wife Maria da Glória Dornelas Ferreira in memory of their son Cristiano Ferreira Varella. The foundation operates Hospital do Câncer de Muriaé, designated by Brazil's Ministry of Health as a Centro de Alta Complexidade em Oncologia (CACON) and serving as the public oncology referral center for 233 pactued municipalities covering more than 3 million inhabitants in the Zona da Mata Mineira and surrounding regions. Approximately 3,800 new cancer cases are received annually, with about 85% of patient encounters delivered entirely free of charge through the SUS public health system.

The hospital offers the full oncology care continuum across a 206-bed, four-block campus with 20 ICU beds, 9 surgical theaters (including a robotic surgery suite launched in 2024 and an integrated/intelligent surgical suite since 2017), 68 outpatient chemotherapy chairs, four radiotherapy rooms, a 5-bed bone marrow transplant unit (since 2022), and Casa de Apoio (212-person free lodging). Diagnostic capability includes a Varian-integrated CT-to-radiotherapy imaging chain, PET-CT (since 2021), MRI, digital mammography, and a clinical laboratory running more than 27,000 tests per month, with molecular biology offering Ion Torrent next-generation sequencing and QuantStudio 3 PCR for BRCA1/BRCA2, JAK2, and BCR-ABL. The institution maintains ONA Nível 3 accreditation (Acreditado com Excelência, highest in Brazil, continuously since 2013, re-certified 2024), 100% ANVISA patient safety compliance (2023), and is currently regionalizing operations via new satellite chemotherapy outpatient clinics inaugurated in Ubá (July 2026) and under construction in Manhuaçu (groundbreaking June 2026).

Revenue mechanics combine SUS reimbursements (the dominant stream), per-procedure reimbursement from approximately 18 health insurance plans (Unimed, Bradesco Saúde, SulAmérica, Cassi, Itaú Saúde, Petrobras Saúde, Postal Saúde, among others), quote-based private pay (booked via WhatsApp), and philanthropic income through PIX donations, payroll deductions, energy-bill rounding partnerships (Moara Energia), Lei Rouanet cultural incentives, and Fundo do Idoso tax-incentive mechanisms. The foundation runs mobile prevention units (carretas) offering free mammograms, PSA, and Papanicolaou tests across municipalities as the primary demand-generation and early-detection channel, and supports a research, residency, and technical-education ecosystem (FCV Ensino e Pesquisa, FCV Escola Técnica with FAMINAS, NEP, CEC simulation center, and the PD&I department). Go-to-market is primarily government/B2B (SUS via AGESUS regulation) supplemented by event-driven community fundraising and convênio direct contracting.

Name

Fundação Cristiano Varella

Legal name

Fundação Cristiano Varella

Website

https://fcv.org.br

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Fundação Cristiano Varella is a non-profit charitable foundation operating Hospital do Câncer de Muriaé, a CACON-designated oncology complex serving 233 municipalities in Minas Gerais with ~3,800 new cancer cases annually, where ~85% of care is delivered free via Brazil's SUS public health system.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Medical and Diagnostic Laboratories (6215)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Oncology hospital services
• Cancer treatment
• Chemotherapy radiotherapy
• Bone marrow transplant
• Oncological surgery

Headquarters

HQ city

Muriaé

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. SUS (Sistema Único de Saúde) Public Health System: Approximately 85% of patient encounters are provided entirely free of charge through the Brazilian public health system. The foundation receives government funding for treating oncology patients from 233 pactued municipalities. It is recognized by the Ministry of Health as a Centro de Alta Complexidade em Oncologia (CACON).
2. Health Insurance (Convênio): The hospital serves patients covered by approximately 18 health insurance plans including Unimed, Bradesco Saúde, SulAmérica, Cassi, Itaú Saúde, Petrobras Saúde, Postal Saúde, and others. Revenue is generated through reimbursements per treatment and procedure.
3. Private/Particular Patients: Private patients pay directly for consultations, exams, and treatments. Pricing is quote-based, not publicly disclosed on the website.
4. Donations and Philanthropic Support: Individual and corporate donations via direct transfer, PIX, bank transfer, payroll deductions ( conta de energia), tax incentive programs (imposto de renda), loose change programs (troco solidário), food donations, and fundraising events (leilões, action between friends). The foundation also receives fiscal incentive donations through Lei Rouanet and Fundo do Idoso.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels11 records

Core offering

Fundação Cristiano Varella operates the Hospital do Câncer de Muriaé, a CACON-designated comprehensive cancer treatment hospital in Minas Gerais, Brazil. The hospital delivers the full oncology care continuum — from mobile screening and prevention campaigns through genetic/molecular diagnostics, imaging, chemotherapy, radiotherapy, robotic and conventional oncological surgery, and bone marrow transplant, to palliative care and follow-up. Approximately 85% of patient encounters are provided free of charge via the SUS public health system; the remainder are reimbursed by ~18 health insurance providers or paid privately.

Product overview

Fundação Cristiano Varella operates Hospital do Câncer de Muriaé as a comprehensive cancer treatment complex offering integrated oncology services across the full care continuum. The core offering centers on the hospital with four main treatment modalities: Quimioterapia (chemotherapy), Radioterapia (radiotherapy), Cirurgia Oncológica (oncological surgery including robotic surgery), and Transplante de Medula Óssea (bone marrow transplant). Supporting these are advanced diagnostic services including Exames Genéticos (genetic testing with Ion Torrent NGS), Exames de Imagem (imaging including PET-CT, CT, MRI, mammography), Análises Clínicas (clinical laboratory with 27,000+ monthly tests), and Anatomia Patológica (pathological anatomy). The institution also provides complementary services including Casa de Apoio (212-bed support house), FCV Escola Técnica (technical nursing school), Centro de Educação Corporativa (corporate education with simulation center), and research departments (PD&I, NEP). Digital services include online exam portals. The foundation serves over 230 municipalities across Minas Gerais.

Differentiator

Problem solved

Functional benefit

Brands

• Ambulatório de Quimioterapia de Ubá: A chemotherapy outpatient unit operated by Fundação Cristiano Varella in Ubá, Minas Gerais, offering infusion chairs, consultation rooms, and pharmacy services for patients from over 20 municipalities in the Ubá microregion.
• Ambulatório de Quimioterapia de Manhuaçu
• Casa de Apoio
• Memorial Cristiano Varella
• FCV Escola Técnica
• Centro de Educação Corporativa (CEC)
• FCV Ensino e Pesquisa
• Núcleo de Ensino e Pesquisa (NEP)

Products and services

• Hospital do Câncer de Muriaé
• Quimioterapia (Chemotherapy)
• Radioterapia (Radiotherapy)
• Cirurgia Oncológica (Oncological Surgery)
• Transplante de Medula Óssea (TMO)
• Exames Genéticos (Genetic Testing)
• Exames de Imagem (Diagnostic Imaging)
• Análises Clínicas (Clinical Laboratory)
• Anatomia Patológica (Pathological Anatomy)
• Casa de Apoio
• Especialidades e Serviços Médicos
• FCV Escola Técnica
• Centro de Educação Corporativa (CEC)
• Residência Médica
• Residência Multiprofissional
• Departamento de Pesquisa, Desenvolvimento e Inovação (PD&I)
• Campanhas de Prevenção (Mobile Prevention Campaigns)
• Portal de Exames Online

Quantifiable outcome

• 3,800+ new cancer cases treated annually, with approximately 85% at no cost to patients
• +5 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Governo de Minas Gerais (Government of Minas Gerais)coreStrategic or Co-development Partner · 1 July 2026Partnership between the Government of Minas Gerais, the Municipality of Ubá, and the Foundation to transform the historic Casa de Saúde Padre Damião building into a chemotherapy outpatient clinic. The state government provided the facility and funding support for the new unit that will serve over 20 municipalities in the Ubá microregion.
• Prefeitura de Ubá (Ubá Municipal Government)coreStrategic or Co-development PartnerThe municipal government of Ubá partnered with the Foundation and the State of Minas Gerais to establish the new chemotherapy outpatient clinic in Ubá, contributing to the adaptation of the facility and serving as a key regional health partner.
• Prefeitura de Manhuaçu (Manhuaçu Municipal Government)coreStrategic or Co-development PartnerThe municipal government of Manhuaçu partnered with the Foundation to build a new chemotherapy outpatient clinic expected to perform approximately 1,200 monthly attendances and 400 chemotherapy infusions per month, serving over 20 municipalities in the Manhuaçu microregion. Ground-breaking ceremony held June 30, 2026.
• FAMINAS (Fundação de Ensino Superior de Minas Gerais)minorStrategic or Co-development PartnerPartnership with FAMINAS for the FCV Escola Técnica, offering an 18-month Technical Nursing Course with 1,850 hours of instruction (1,250 theoretical/practical + 600 supervised internship hours) at the Hospital do Câncer de Muriaé and partner institutions.
• AGESUS (Sistema de Regulação)coreTechnology or IntegrationAGESUS is the health regulation system used by municipal health secretariats to refer patients to the Hospital do Câncer de Muriaé. It enables rapid information exchange between municipal regulation units and the hospital, improving access and care quality for SUS patients from 233 municipalities.
• Moara EnergiaminorStrategic or Co-development PartnerPartnership with Moara Energia to launch the Energia10 project, enabling energy consumers to receive a 10% discount on their electricity bill each month, with a portion of the savings automatically donated to the Foundation.

Scale indicators10 records

Recent moves16 records

Expansion highlights6 records

Direct peers

• Hospital de Amor: Formerly Hospital de Câncer de Barretos, it is Brazil's largest non-profit dedicated oncology hospital. It shares FCV's charitable foundation model, CACON-equivalent designation, SUS-heavy patient mix, and full-spectrum cancer services including bone marrow transplant and prevention units. Most directly comparable peer.
• Hospital Erasto Gaertner: Non-profit dedicated oncology hospital in Curitiba, Paraná, founded in 1972. Closely matches FCV's charitable foundation structure, CACON-grade service scope, and SUS-dependent revenue model. Operates as a regional referral center for Paraná state.
• A.C. Camargo Cancer Center: Dedicated oncology hospital and research center in São Paulo, offering comprehensive cancer care, residency programs, and advanced diagnostics. Comparable as a high-complexity oncology reference center with teaching/research infrastructure, though located in a major metropolitan area.

Emerging players

• Hospital Pequeno Príncipe: Non-profit pediatric hospital in Curitiba with oncology services, research arm, and teaching programs. Comparable on non-profit foundation model, CACON-equivalent pediatric designation, and SUS-heavy mix, though focused on pediatric oncology specifically.
• Grupo Oncoclínicas: Largest oncology specialty clinic network in Brazil, offering chemotherapy, radiotherapy, and precision diagnostics across multiple states. Comparable as a multi-site oncology operator, but operates on a for-profit, investor-backed model rather than a non-profit foundation model.

Broad incumbents

• Rede D'Or São Luiz: Largest private hospital network in Brazil with oncology services across multiple units. Comparable on hospital operations, advanced technology, and multi-site expansion, but operates for-profit and focuses on general tertiary care rather than dedicated oncology.
• Hospital Sírio-Libanês: Major São Paulo private hospital with a well-established oncology center, clinical research arm (Instituto Sírio-Libanês), and teaching programs. Comparable on advanced oncology technology and residency training, though with a different patient mix skewed to private insurance.
• BP - Beneficência Portuguesa de São Paulo: Large São Paulo-based hospital network with significant oncology services, teaching programs, and a charitable foundation structure. Comparable as a broad incumbent hospital with oncology capabilities and philanthropic roots, though operating at much larger scale in a different market.
• Hospital Israelita Albert Einstein: Large private tertiary hospital in São Paulo with a strong oncology center, residency programs, and research institute (Einstein). Comparable on advanced technology and teaching infrastructure, but operates as a broad private system rather than a dedicated oncology charity.

Others

• INCA - Instituto Nacional de Câncer: Brazilian federal government cancer institute responsible for cancer policy, surveillance, and reference oncology hospitals (Hospital do Câncer I, II, III, IV in Rio de Janeiro). Not a direct competitor but a critical policy/regulatory counterpart that shapes CACON designations and SUS oncology protocols.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/FCVarella
• Facebookfacebook.com/hospitaldocancerdemuriae
• LinkedInlinkedin.com/company/fundacaocristianovarella
• Instagraminstagram.com/fundacaocristianovarella

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundação Cristiano Varella